Curaleaf’s Dr. Erridge and Dr. Sodergren Win at CIC Awards 2025!

The Cannabis Industry Council (CIC) Awards 2025 represented the individuals driving progress, innovation and compassion in the cannabis industry.

We are proud to announce that our very own Dr. Simon Erridge and Dr. Mikael Sodergren were recognised as winners, in the category ‘Contribution to Science’.

This prestigious recognition highlights their profound contributions to research and their relentless commitment to evidence-based progress, innovation, and, most importantly, improving patient access to medical cannabis.

The Power of Data-Driven Care

The work of Dr. Sodergren and Dr. Erridge is the clinical engine behind Curaleaf’s services. Their dedication to a data-driven approach has been instrumental in scaling our clinical services, which now support tens of thousands of patients across the UK, Poland, and Sweden.

Pioneering UK Standards: They are the driving forces behind Curaleaf Clinic, the UK’s first CQC-registered medical cannabis clinic.

Combining Research and Care: With the UK Medical Cannabis Registry, Mikael and Simon have successfully combined cutting-edge patient care and real world evidence with rigorous clinical research, setting the highest standard for the industry.

Their achievement is a well-deserved celebration of their commitment and efforts to ensure that patient care in this field is supported by the highest level of clinical evidence.

We are also proud that Dr Gracia Mwimba, Curaleaf Clinic, was shortlisted for the UK Clinician of the Year Award. All the nominees are leading doctors ensuring safe, evidence-based cannabis medicine prescribing across the UK.

Congratulations to everyone recognised!

Thank you to the Cannabis Industry Council for hosting such an important event and for recognising the impressive individuals who are dedicated to driving positive, impactful change within the medical cannabis industry.

Latest news

Curaleaf News
We’re thrilled to announce a significant expansion into the Australian market through an exclusive manufacture…